RedHill Biopharma Ltd.
Sphingosine kinase 2 inhibitor for treating coronavirus infection

Last updated:

Abstract:

The disclosure is directed to ABC294640, as free base or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection.

Status:
Grant
Type:

Utility

Filling date:

15 Oct 2021

Issue date:

21 Jun 2022